Shareholders meeting

Corporate Office: Registered Office: Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A, Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi, 560076, India Navi Mumbai - 400703, India T: +91 80 6784 0738 T: +91 22 2789 2924 F: +91 22 2789 2942 Date: September 23, 2026 BSE Limited National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Dalal Street, Mumbai- 400 001 Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Scrip Code: 544292 Symbol: ONESOURCE Dear Madam/ Sir, Subject: Proceedings of the 19th Annual General meeting (AGM) (2nd AGM Post Listing) of the Company We wish to inform you that the 19th AGM of the Company was held on Wednesday, September 23, 2026 at 17:00 hrs IST through video conference and concluded at 18:02 hrs IST. Pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed summary of proceedings of the AGM. This is for your information and records. For and on behalf of OneSource Specialty Pharma Limited Trisha A Company Secretary and Compliance Officer Membership Number: A47635 OneSource Specialty Pharma Limited Formerly Stelis Biopharma Limited info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497 Corporate Office: Registered Office: Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A, Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi, 560076, India Navi Mumbai - 400703, India T: +91 80 6784 0738 T: +91 22 2789 2924 F: +91 22 2789 2942 SUMMARY OF PROCEEDINGS OF 19TH ANNUAL GENERAL MEETING OF THE COMPANY HELD ON WEDNESDAY, SEPTEMBER 23, 2026, FROM 17:00 HRS IST TO 18:02 HRS IST THROUGH VIDEO CONFERENCE The 19th Annual General Meeting (AGM) of OneSource Specialty Pharma Limited, being the 2nd AGM post listing, was held on Wednesday, September 23, 2026, from 17:00 hrs IST to 18:02 hrs IST through Video Conference/ Other Audio- Visual Means (VC/ OAVM). Trisha A, Company Secretary of the Company, welcomed the shareholders and confirmed that the meeting was convened in compliance with the Companies Act, 2013, the applicable Rules made there under, Secretarial Standard on General Meetings (SS-2), the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the relevant circulars issued by the Ministry of Corporate Affairs and SEBI. Thereafter, Trisha, introduced the members of the Board and Key Management team following which the Board members greeted the Shareholders. In attendance, participated form the Corporate office in Bengaluru, India: Arun Kumar Chairperson of the Board & Non-Executive Director Neeraj Sharma Chief Executive Officer and Managing Director Member of Audit Committee, Risk Management Committee, Stakeholders Relationship Committee, and Corporate Social Responsibility Committee Anurag Bhagania Chief Financial Officer Management Representative of Risk Management Committee Trisha A Company Secretary and Compliance Officer Directors Present through video conference (VC): Debarati Sen Independent Director Chairperson of Corporate Social Responsibility Committee Member of Audit Committee, Nomination and Remuneration Committee, and Risk Management Committee Dr. Claudio Albrecht Independent Director Member of Nomination and Remuneration Committee Colin Bond Independent Director Chairperson of Audit Committee Dr. Rashmi Barbhaiya Independent Director Member of Stakeholders Relationship Committee Vijay Karwal Independent Director Chairperson of Nomination and Remuneration Committee, and Risk Management Committee Member of Audit Committee, and Corporate Social Responsibility Committee Bharat D Shah Non-Executive Director Chairperson of Stakeholders Relationship Committee Member of Nomination and Remuneration Committee, and Corporate Social Responsibility Committee OneSource Specialty Pharma Limited Formerly Stelis Biopharma Limited info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497 Corporate Office: Registered Office: Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A, Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi, 560076, India Navi Mumbai - 400703, India T: +91 80 6784 0738 T: +91 22 2789 2924 F: +91 22 2789 2942 Other attendees through VC: G Prakash Representative & partner of M/s. B S R & Co LLP, proposed to be appointed as the Statutory Auditors of the Company Sathya P Koushik Representative & partner of M/s. Deloitte Haskins & Sells, the retiring Statutory Auditors Nidhi Shree J Scrutinizer, Partner, M/s. V Sreedharan & Associates, Practicing Company Secretaries Vivek Kumar Representative & partner of M/s DV & Associates, Company Secretaries, Secretarial Auditor Shareholders Present: Total 81 Shareholders holding 3,46,04,605 shares, attended the meeting through VC/ OAVM. Thereafter, National Securities Depository Limited (NSDL) confirmed presence of requisite quorum for the meeting. Arun Kumar chaired the meeting, called it to order, greeted the shareholders and invited Neeraj Sharma to brief the shareholders on the Company’s performance for the financial year ended March 31, 2026, along with other key matters. Thereafter, Neeraj Sharma provided the key strategic updates to the Shareholders. Post Neeraj’s presentation, the moderator opened the Question & Answer session for the Speaker Shareholders to ask their queries. Shareholders who had registered with the Company to speak at the AGM were provided an opportunity to express their views/ raise their queries relating to the Company and agenda items of the AGM. All the queries were adequately responded by Neeraj Sharma and Anurag Bhagania. Since the Notice convening the AGM and the Integrated Annual Report for FY26 had already been circulated to all the Shareholders, the Notice of the AGM, the Board’s Report and the Auditor’s Report were taken as read. Shareholders were informed that: 1. Auditor’s Report for the Consolidated and Standalone Financial Statements of the Company for the financial year ended March 31, 2026, does not contain any qualifications, observations or adverse remarks or comments. 2. Requisite Statutory Registers and other documents referred to in the AGM Notice were available for inspection electronically by the Shareholders. 3. Certificate from Secretarial Auditor of the Company, certifying that the existing ESOP Scheme of the Company has been implemented in accordance with SEBI Regulations and in line with Shareholders’ approval, was also available for e-inspection. The Shareholders were further informed that the Company had provided to the members facility to cast their votes electronically, on all resolutions set forth in the Notice of the 19th AGM (2nd post listing) through remote e-voting provided by NSDL. The remote e-voting facility was open from, Friday, September 18, 2026 (9.00 hours IST) to Tuesday, September 22, 2026 (17:00 hours IST). Shareholders who attended the AGM and had not cast their votes through remote e-voting prior to the meeting were provided an opportunity to cast their votes during the AGM through the e-voting facility provided by NSDL. OneSource Specialty Pharma Limited Formerly Stelis Biopharma Limited info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497 Corporate Office: Registered Office: Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A, Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi, 560076, India Navi Mumbai - 400703, India T: +91 80 6784 0738 T: +91 22 2789 2924 F: +91 22 2789 2942 The following items of business, as per the Notice of the 19th AGM (2nd post listing) dated Wednesday, September 23, 2026 were transacted at the meeting: Ordinary Business 1. Adoption of Financial Statements Ordinary Resolution 2. Re-appointment of Neeraj Sharma (DIN: 09402652), retiring Director Ordinary Resolution 3. Appointment and Fixation of Remuneration of Statutory Auditors Ord [Showing first 8,000 characters — download PDF for full document]